Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FCY3M
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $193,412
Award facts
- Contract value 100% obligated
- $193,411.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $193,411.88 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens. The contract was awarded on January 7, 2026, with an ultimate completion date of January 8, 2026, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order was issued without a set-aside designation, competing on a full and open basis. AmerisourceBergen Drug Corp serves as a child entity under its parent company Cencora, Inc., which does business as AmerisourceBergen and functions as a major pharmaceutical distributor supporting federal medical procurement needs.
This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 through December 2026. The overarching IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including critical medical commodities such as specialty medications, brand-name and generic drugs, vaccines, and related medical supplies. The supply of Dupixent, a biologic medication used to treat conditions such as eczema and asthma, supports the Defense Health Agency and other federal healthcare systems' mission to provide essential pharmaceutical therapies to military beneficiaries.
Quick answers
Who was awarded contract SPE2DR26FCY3M?
SPE2DR26FCY3M was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FCY3M worth?
The government has obligated $193,412 on SPE2DR26FCY3M.
Is contract SPE2DR26FCY3M an order under another contract?
Yes. SPE2DR26FCY3M is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCY3M competed?
The extent of competition for SPE2DR26FCY3M was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award